📰 Controlled Study News
Controlled Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Controlled Study. Real-time updates on events, politics, business and more.
November 25, 2023
Milestone Pharmaceuticals Inc. recently announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and statistically superior ventricular rate reduction and improved symptom-relief in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) compared to placebo. The findings were presented during the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA.
November 11, 2023
Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate compared to...
October 21, 2023
Published late-breaking clinical data presented at TCT 2023
October 19, 2023
The association between different “a posteriori” (data-driven) diets and the risk of lung cancer.
October 19, 2023
The associations between diet, rosacea, and acne.
September 27, 2023
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2...
May 7, 2023
Despite the widespread belief that HPV infection is a singularly lethal force against which we only have vaccination ...
September 16, 2022
September 16, 2022 Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) proceduresPhilips Engagement Hub at TCT to feature a range of
September 16, 2022
Investegate announcements from Royal Philips, Philips showcases clinical data and solutions designed to deliver better cardiac care with greater efficiency at TCT 2022
September 16, 2022
Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) procedures